查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1950526

周邊血管栓塞系統市場（依產品類型、材料、技術、線圈尺寸、適應症、最終用戶和分銷管道分類），全球預測，2026-2032年

Peripheral Coil Embolization System Market by Product Type, Material, Technology, Coil Size, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年外周線圈栓塞系統市場價值為 2.1963 億美元，預計 2026 年將成長至 2.2745 億美元，預計到 2032 年將達到 3.4591 億美元，複合年成長率為 6.70%。

關鍵市場統計數據
基準年 2025 2.1963億美元
預計年份：2026年 2.2745億美元
預測年份 2032 3.4591億美元
複合年成長率 (%) 6.70%

周邊血管栓塞術融合了介入放射學、神經外科和血管內治療。這類裝置在現代臨床實踐中發揮著至關重要的作用，可用於閉塞病變血管、穩定動脈瘤以及治療各種血管畸形。過去十年間，臨床技術和裝置設計同步發展。影像導引和導管技術的進步提高了手術精度，而線圈幾何形狀和材料成分的改進則提升了栓塞的持久性和操作靈活性。

因此，包括醫院、門診手術中心和專科診所相關人員在評估器械選擇時，不僅考慮即時臨床療效，還考慮輸送性、與微導管的兼容性以及長期血管重塑的證據。臨床醫師越來越傾向選擇既能最大限度降低血栓栓塞風險，又能提供良好貼合性和填充密度的彈簧圈。同時，專注於互補技術的創新路徑，例如促進組織整合的聚合物塗層和生物活性表面處理，也越來越受到重視。本文為戰略決策提供了背景資訊。器械開發商必須使產品創新與不斷變化的臨床偏好、監管要求以及不同的終端用戶實際操作情況相適應。

技術創新、監管調整和臨床實踐的轉變正在重新定義彈簧圈栓塞治療的治療路徑和醫護人員動態。

周邊血管栓塞術的格局正因三大相互關聯的因素而迅速變化：技術創新、臨床實踐模式的改變以及監管和報銷政策的演變。線圈材料和製造技術的進步，包括水凝膠膨脹技術和聚合物塗層表面，提高了栓塞術的性能上限。這些創新透過提高栓塞密度和降低再通率，直接轉化為臨床獲益，從而改變了臨床醫師的選擇和治療方案。

評估美國2025年對線圈栓塞術相關人員徵收關稅的累積經濟影響、供應鏈影響和創新影響

2025年關稅的實施為全球醫療設備供應鏈引入了新的變數，對零件採購、製造地選擇和定價策略產生了連鎖反應。依賴跨境供應鏈的醫療器材和零件面臨著迫在眉睫的成本壓力，迫使製造商權衡利弊：是自行承擔額外成本、將其轉嫁給買家，還是重新設計籌資策略。對許多供應商而言，最直接的應對措施是加快近岸外包，並深化與位於關稅優惠地區的契約製造的合作，從而在保持單位成本優勢的同時，維持對熟練產能的利用。

從產品、適應症、最終用戶、分銷、材料、技術和線圈尺寸等方面識別觀點變化，從而指導商業化選擇。

了解市場區隔的細微差別對於使產品開發和商業化策略與臨床及機構需求保持一致至關重要。根據產品類型，市場參與企業將產品分為可脫卸彈簧圈、纖維彈簧圈、液壓彈簧圈和推入式彈簧圈，其中可脫卸彈簧圈又可細分為電解、機械式和氣動式脫卸機制。這種產品層面的細分非常重要，因為每種設計都有不同的操作特性和與輔助設備的兼容性。臨床應用主要基於適應症，涵蓋動靜脈畸形、腦動脈瘤治療、顱內靜脈竇血栓症和周邊血管畸形，每種適應症都對應不同的手術流程、療效評估指標和報銷機制。

美洲、歐洲、中東和非洲以及亞太地區的區域績效和機會矩陣重點關注了市場准入、報銷和推廣應用方面的促進因素。

區域趨勢影響臨床應用和商業策略，美洲、歐洲、中東和非洲地區以及亞太地區的促進因素各不相同。在美洲，成熟的醫院基礎設施、許多關鍵意見領袖（KOL）以及完善的醫保報銷機制促進了先進線圈技術的快速應用。同時，成本控制壓力和醫保支付方的嚴格審查也促使人們關注可證實的臨床效益和可靠的衛生經濟學證據。在歐洲、中東和非洲地區，不同的法規環境和不斷變化的醫保報銷機制意味著不同地區的市場准入情況存在差異。能夠適應區域監管協調工作並採取靈活定價策略的製造商往往能夠獲得更廣泛的市場滲透。

公司層面的競爭與合作動態影響整個栓塞生態系中的產品藍圖、臨床證據產生與策略聯盟。

在栓塞線圈領域，企業層面的發展趨勢取決於現有醫療設備產品組合、針對性創新和策略夥伴關係的整合。成熟的醫療設備製造商利用其現有的分銷網路和穩固的臨床關係來支持新型線圈的上市，而專業製造商和敏捷的Start-Ups公司則通常透過專注於生物活性塗層或新型脫出機制等技術進步來脫穎而出。合作模式日益普遍，成熟企業與專業創新者簽訂共同開發和授權協議，以加快產品臨床應用速度，而契約製造製造商在擴大生產規模和控制成本方面發揮關鍵作用。

為產業領導者提供切實可行的策略建議，以加速創新、確保供應鏈韌性、最佳化市場推廣策略並擴大臨床應用。

為保持發展動能並抓住新的機遇，產業領導者應採取一系列相互關聯的策略。首先，應優先考慮供應鏈韌性，實現零件採購多元化並投資於區域組裝能力。這將有助於降低政策主導的成本波動風險，並確保供應的持續性。其次，應加快推進能夠證明患者療效顯著改善的臨床證據項目，並專注於對支付方和醫院採購委員會至關重要的終點指標。高品質的真實世界數據和註冊登記數據將有助於醫保報銷談判和臨床醫生採納相關技術。

為了確保分析的嚴謹性和對決策的相關性，我們採用穩健的混合調查方法，將主要專家研究與次要證據綜合相結合。

本分析所依據的研究採用混合方法，結合了來自關鍵相關人員的對話、有針對性的二手研究以及嚴謹的分析綜合，對證據進行三角驗證。主要投入包括：對介入放射學和神經外科的關鍵高管進行結構化訪談；與醫院和門診手術中心的採購和供應鏈高管進行深入討論；以及諮詢製造和監管專家以檢驗運營假設。這些工作提供了關於設備性能偏好、臨床工作流程和採購優先事項的定性見解。

研究結果提供了重要的策略見解，突顯了投資重點、商業化重點領域以及相關人員的協作參與，以維持長期成長。

總之，周邊血管栓塞術生態系統正處於轉折點，其特點是材料創新、手術流程改進和供應鏈監管加強。結合了更優的生物相互作用、可靠的脫落機制以及與現有手術工具包無縫整合的器械越來越受到臨床醫生的青睞。同時，政策變化和關稅相關的成本壓力也凸顯了生產靈活性和採購多元化的重要性，並強調了技術卓越與營運韌性並重的必要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 周邊彈簧圈栓塞系統市場（依產品類型分類）

  • 可拆卸線圈
    • 電解解吸線圈
    • 機械可拆卸線圈
    • 氣動可拆卸線圈
  • 光纖線圈
  • 水力線圈
  • 推式線圈

9. 周邊彈簧圈栓塞系統市場（依材料分類）

  • 水凝膠線圈
  • 鉑金線圈
  • 鉑鎢線圈

10. 周邊線圈栓塞系統市場（依技術分類）

  • 裸露金屬線圈
  • 生物活性線圈
  • 聚合物塗層線圈

11. 依線圈尺寸分類的外周線圈栓塞系統市場

  • 大線圈
  • 宏線圈
  • 微線圈

12. 周邊血管栓塞系統市場（依適應症分類）

  • 動靜脈畸形
  • 腦動脈瘤
  • 顱內靜脈竇血栓症
  • 周邊血管畸形

13. 周邊線圈栓塞系統市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 研究所
  • 專科診所

14. 周邊線圈栓塞系統市場（依分銷管道分類）

  • 直銷
  • 經銷商
  • 線上管道

15. 周邊彈簧圈栓塞系統市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

16. 周邊彈簧圈栓塞系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

17. 各國周邊血管栓塞系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

18. 美國周邊血管栓塞系統市場

19. 中國周邊血管栓塞系統市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acandis GmbH & Co. KG
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • Balt Extrusion SAS
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cordis Corporation
  • EndoShape, Inc.
  • Guerbet SA
  • InspireMD, Inc.
  • Johnson & Johnson
  • Kaneka Corporation
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Shape Memory Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Vesalio SA
  • WL Gore & Associates, Inc.
Product Code: MRR-4F7A6D4FD8BD

The Peripheral Coil Embolization System Market was valued at USD 219.63 million in 2025 and is projected to grow to USD 227.45 million in 2026, with a CAGR of 6.70%, reaching USD 345.91 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 219.63 million
Estimated Year [2026] USD 227.45 million
Forecast Year [2032] USD 345.91 million
CAGR (%) 6.70%

The peripheral coil embolization landscape sits at the intersection of interventional radiology, neurosurgery, and endovascular therapy. Devices in this class are integral to contemporary practice for occluding pathological vascular structures, stabilizing aneurysms, and managing a range of vascular malformations. Over the last decade clinical techniques and device engineering have matured in parallel: imaging guidance and catheter technologies have improved procedural precision, while incremental design refinements in coil geometry and material composition have enhanced occlusion durability and handling characteristics.

Consequently, stakeholders across hospitals, ambulatory surgical centers, and specialty clinics now evaluate device choice not only on immediate clinical outcomes but also on deliverability, microcatheter compatibility, and evidence of long-term vessel remodeling. Clinicians increasingly prioritize coils that balance conformability with packing density while minimizing thromboembolic risk. At the same time, innovation pathways emphasize adjunctive technologies such as polymer coatings and bioactive surface treatments to accelerate tissue integration. This introduction establishes a context for strategic decision-making: device developers must align product innovation with evolving clinical preferences, regulatory expectations, and the operational realities of diverse end users.

How technological innovation, regulatory recalibration, and clinical practice shifts are redefining treatment pathways and supplier dynamics in coil embolization

The landscape for peripheral coil embolization is changing rapidly under the influence of three interlinked forces: technological innovation, shifting clinical practice patterns, and an evolving regulatory and reimbursement environment. Advances in coil materials and manufacturing, including hydrogel-enabled expansion technologies and polymer-coated surfaces, have moved the performance ceiling forward. These technical innovations translate directly into clinical benefits by improving packing density and reducing recanalization, which in turn alter operator preference and procedural algorithms.

Clinical practice has also been influenced by enhanced imaging modalities and procedural adjuncts. High-resolution intraprocedural imaging and improved microcatheter designs allow clinicians to access distal anatomies and deploy complex constructs with greater confidence. As a result, indications previously considered high risk are increasingly treatable with endovascular approaches. In parallel, regulatory pathways in several jurisdictions are accelerating access for devices backed by robust clinical evidence and real-world performance data, prompting manufacturers to invest early in pivotal studies and post-market registries. Taken together, these shifts are recalibrating value propositions across the product spectrum, favoring devices that combine proven clinical efficacy with ease of use and predictable supply chain performance.

Assessing the cumulative economic, supply chain, and innovation impacts of the United States tariffs implemented in 2025 on coil embolization stakeholders

The tariff measures enacted in 2025 introduced a new variable into the global medical device supply chain, with cascading effects on component sourcing, manufacturing location decisions, and pricing strategies. Devices and subcomponents that relied on cross-border supply chains experienced immediate cost pressure, prompting manufacturers to evaluate the trade-offs between absorbing incremental costs, passing them to purchasers, or redesigning sourcing strategies. For many suppliers the most expedient response was to accelerate nearshoring and to deepen partnerships with contract manufacturers located in tariff-favored jurisdictions, thereby preserving unit economics while maintaining access to skilled production capacity.

In addition to supply chain reconfiguration, the tariffs have intensified scrutiny on total landed cost and on regulatory compliance workflows for imported components. Providers and procurement teams are responding by instituting longer-term supplier contracts and by requiring greater transparency regarding component provenance and quality management. Importantly, the tariffs have also shifted investment calculus for new product introductions. Manufacturers targeting markets heavily affected by tariffation have prioritized modular designs and local assembly models to reduce exposure to cross-border duties. Looking forward, stakeholders who establish diversified sourcing strategies and who invest in manufacturing agility will be better positioned to mitigate the ongoing policy-driven volatility and to sustain clinical and commercial momentum.

Integrated segmentation perspectives revealing product, indication, end-user, distribution, material, technology, and coil-size dynamics that guide commercialization choices

A nuanced understanding of segmentation is essential for aligning product development and commercialization strategies with clinical and institutional needs. Based on product type, market participants distinguish among detachable coils, fibered coils, HydroCoils, and pushable coils, and within detachable coils there is further differentiation into electrolytic, mechanical, and pneumatic detachable mechanisms. This product-level granularity matters because each design imparts distinct handling characteristics and compatibility profiles with adjunct devices. Based on indication, the clinical focus spans arteriovenous malformations, cerebral aneurysm management, intracranial venous sinus thrombosis, and peripheral vascular malformations, with distinct procedural workflows, outcome metrics, and reimbursement constructs tied to each indication.

Based on end user, adoption dynamics vary across ambulatory surgical centers, hospitals, research institutes, and specialty clinics; each setting imposes different purchasing cycles, inventory practices, and clinical staffing models that influence product selection. Based on distribution channel, manufacturers balance direct sales, distributor relationships, and online channels to reach heterogeneous buyers while optimizing support and training. Based on material, coil choices include hydrogel coils, platinum coils, and platinum-tungsten coils, where material selection affects radiopacity, conformability, and biological interaction. Based on technology, devices are differentiated as bare metal coils, bioactive coils, and polymer-coated coils with implications for healing responses and retreatment rates. Finally, based on coil size, therapeutic approaches segment across large coils, macrocoils, and microcoils, each suited to specific vessel sizes and target anatomies. Together, these segmentation lenses provide a comprehensive framework for prioritizing R&D investments, tailoring clinical education, and calibrating go-to-market strategies.

Regional performance and opportunity matrices across the Americas, Europe Middle East & Africa, and Asia-Pacific highlighting access, reimbursement, and adoption drivers

Regional dynamics shape both clinical adoption and commercial strategy, with differentiated drivers across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, a mature hospital infrastructure, a concentration of key opinion leaders, and established reimbursement pathways support rapid uptake of advanced coil technologies; conversely, cost containment pressures and payer scrutiny incentivize demonstrable clinical benefit and robust health economic evidence. In Europe Middle East & Africa, heterogeneous regulatory environments and variable reimbursement mechanisms create a patchwork of access; manufacturers that align with regional regulatory harmonization efforts and that develop adaptable pricing strategies tend to achieve broader penetration.

In Asia-Pacific, accelerating investments in interventional capacity, expanding procedural volumes, and a growing base of domestic manufacturers are shifting the competitive landscape. Regional stakeholders here emphasize affordability, local regulatory approvals, and training programs to develop operator proficiency. Across all regions, cross-border collaboration on clinical registries and post-market surveillance is becoming a de facto expectation, enabling faster recognition of best practices and facilitating iterative product improvements. For companies expanding geographically, a regionally nuanced approach that balances clinical evidence generation with tailored commercial and support models yields the most durable results.

Competitive and collaborative company-level dynamics shaping product roadmaps, clinical evidence generation, and strategic partnerships across the coil embolization ecosystem

Company-level dynamics in the coil embolization space are defined by a blend of legacy device portfolios, targeted innovation, and strategic partnerships. Incumbent medical device firms leverage existing sales networks and established clinical relationships to support new coil introductions, while specialized manufacturers and agile startups often differentiate through focused technology advancements such as bioactive coatings or novel detachment mechanisms. Collaborative models are increasingly common: larger firms enter co-development or licensing agreements with specialist innovators to accelerate time-to-clinic, and contract manufacturing organizations play a pivotal role in scaling production while enabling cost control.

Clinical data and post-market evidence remain decisive competitive assets, prompting companies to invest in investigator-initiated studies, registries, and real-world evidence programs. Additionally, services that improve procedural efficiency, such as comprehensive training modules and digital tools for case planning, have become differentiators that extend beyond the device itself. For corporate development teams, strategic acquisitions and minority investments are attractive pathways to acquire complementary technologies or to secure intellectual property that addresses procedural pain points. Overall, companies that combine robust clinical evidence generation with flexible supply strategies and integrated customer support are most likely to sustain and extend their market presence.

Actionable strategic recommendations for industry leaders to accelerate innovation, secure resilient supply chains, optimize go-to-market approaches, and expand clinical adoption

Industry leaders should pursue a set of interlocking strategies to maintain momentum and to capture emerging opportunities. First, prioritize supply chain resilience by diversifying component sourcing and investing in regional assembly capabilities; doing so reduces exposure to policy-driven cost shifts and supports continuity of supply. Second, accelerate clinical evidence programs that demonstrate meaningful outcome improvements, focusing on endpoints that resonate with payers and hospital procurement committees. High-quality real-world data and registry participation will support reimbursement dialogues and clinician adoption.

Third, invest in product modularity and compatibility, ensuring new coils integrate smoothly with prevailing microcatheter platforms and imaging workflows; compatibility reduces training friction and shortens adoption cycles. Fourth, enhance value-based propositions through bundled service offerings that include training, case planning, and outcome monitoring, thereby positioning products as part of integrated care pathways rather than as stand-alone devices. Fifth, tailor regional go-to-market approaches by aligning pricing, clinical education, and regulatory engagement to local conditions; this targeted approach accelerates penetration in diverse healthcare landscapes. Finally, pursue strategic partnerships for shared development risks and to access specialized manufacturing or distribution capabilities, ensuring that capital and operational resources are deployed efficiently toward high-impact innovations.

Robust mixed-method research methodology combining primary expert engagement and secondary evidence synthesis to ensure analytical rigor and decision relevance

The research underpinning this analysis relies on a mixed-methods approach designed to triangulate evidence from primary stakeholder engagement, targeted secondary research, and rigorous analytical synthesis. Primary inputs include structured interviews with clinical key opinion leaders across interventional radiology and neurosurgery, in-depth discussions with procurement and supply chain executives in hospitals and ambulatory surgical centers, and consultations with manufacturing and regulatory specialists to validate operational assumptions. These engagements provided qualitative insight into device performance preferences, clinical workflows, and sourcing priorities.

Secondary evidence synthesis drew on peer-reviewed clinical literature, procedural guidelines, regulatory filings, and public corporate disclosures to corroborate primary findings and to map technology trajectories. Data were analyzed through a framework that aligns product attributes with clinical indications, end-user requirements, distribution channel dynamics, material properties, technology type, and coil size. Throughout the process, findings were validated through iterative expert review and scenario testing to ensure robustness and decision relevance. This methodological rigor supports a transparent linkage between observed clinical trends, operational constraints, and strategic implications for stakeholders.

Conclusive strategic takeaways emphasizing priority investments, commercialization focus areas, and coordinated stakeholder engagement to sustain long-term growth

In conclusion, the peripheral coil embolization ecosystem is at an inflection point characterized by material innovation, procedural refinement, and heightened supply chain scrutiny. Devices that combine improved biological interaction, reliable detachment mechanisms, and seamless integration with existing procedural toolkits are increasingly favored by clinicians. At the same time, policy shifts and tariff-related cost pressures have elevated the importance of manufacturing agility and sourcing diversity, underscoring that technical excellence must be matched with operational resilience.

Strategically, manufacturers should commit to evidence-led product introductions, regionally tailored commercialization models, and partnerships that accelerate both clinical validation and scale-up. For healthcare providers and payers, the emphasis will be on demonstrable improvements in clinical outcomes, care efficiency, and total cost of care. Those organizations that proactively align product design, clinical research, and supply chain strategies will be best positioned to translate innovation into sustained clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Coil Embolization System Market, by Product Type

  • 8.1. Detachable Coils
    • 8.1.1. Electrolytic Detachable Coils
    • 8.1.2. Mechanical Detachable Coils
    • 8.1.3. Pneumatic Detachable Coils
  • 8.2. Fibered Coils
  • 8.3. HydroCoils
  • 8.4. Pushable Coils

9. Peripheral Coil Embolization System Market, by Material

  • 9.1. Hydrogel Coils
  • 9.2. Platinum Coils
  • 9.3. Platinum-Tungsten Coils

10. Peripheral Coil Embolization System Market, by Technology

  • 10.1. Bare Metal Coils
  • 10.2. Bioactive Coils
  • 10.3. Polymer Coated Coils

11. Peripheral Coil Embolization System Market, by Coil Size

  • 11.1. Large Coils
  • 11.2. Macrocoils
  • 11.3. Microcoils

12. Peripheral Coil Embolization System Market, by Indication

  • 12.1. Arteriovenous Malformations
  • 12.2. Cerebral Aneurysm
  • 12.3. Intracranial Venous Sinus Thrombosis
  • 12.4. Peripheral Vascular Malformations

13. Peripheral Coil Embolization System Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Research Institutes
  • 13.4. Specialty Clinics

14. Peripheral Coil Embolization System Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Distributors
  • 14.3. Online Channels

15. Peripheral Coil Embolization System Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Peripheral Coil Embolization System Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Peripheral Coil Embolization System Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Peripheral Coil Embolization System Market

19. China Peripheral Coil Embolization System Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Acandis GmbH & Co. KG
  • 20.6. AngioDynamics, Inc.
  • 20.7. Asahi Intecc Co., Ltd.
  • 20.8. Balt Extrusion S.A.S.
  • 20.9. Becton, Dickinson and Company
  • 20.10. Boston Scientific Corporation
  • 20.11. Cardinal Health, Inc.
  • 20.12. Cordis Corporation
  • 20.13. EndoShape, Inc.
  • 20.14. Guerbet S.A.
  • 20.15. InspireMD, Inc.
  • 20.16. Johnson & Johnson
  • 20.17. Kaneka Corporation
  • 20.18. Medikit Co., Ltd.
  • 20.19. Medtronic plc
  • 20.20. Merit Medical Systems, Inc.
  • 20.21. MicroPort Scientific Corporation
  • 20.22. Penumbra, Inc.
  • 20.23. Phenox GmbH
  • 20.24. Shape Memory Medical Inc.
  • 20.25. Stryker Corporation
  • 20.26. Terumo Corporation
  • 20.27. Vesalio SA
  • 20.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PNEUMATIC DETACHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PNEUMATIC DETACHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PNEUMATIC DETACHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FIBERED COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FIBERED COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FIBERED COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROCOILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROCOILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROCOILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PUSHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PUSHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PUSHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM-TUNGSTEN COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM-TUNGSTEN COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM-TUNGSTEN COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE METAL COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE METAL COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE METAL COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYMER COATED COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYMER COATED COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYMER COATED COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY LARGE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY LARGE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY LARGE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MACROCOILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MACROCOILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MACROCOILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROCOILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROCOILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROCOILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL VENOUS SINUS THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL VENOUS SINUS THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL VENOUS SINUS THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL VASCULAR MALFORMATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL VASCULAR MALFORMATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL VASCULAR MALFORMATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)